Hubei Fuxing Science and Technology Co.,Ltd
000926.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4,044 | CN¥4,086 | CN¥4,066 | CN¥4,038 |
| - Cash | CN¥1,155 | CN¥2,260 | CN¥2,744 | CN¥4,718 |
| + Debt | CN¥3,464 | CN¥6,555 | CN¥7,396 | CN¥11,371 |
| Enterprise Value | CN¥6,353 | CN¥8,382 | CN¥8,717 | CN¥10,691 |
| Revenue | CN¥8,757 | CN¥5,508 | CN¥15,142 | CN¥12,544 |
| % Growth | 59% | -63.6% | 20.7% | – |
| Gross Profit | CN¥1,344 | CN¥1,367 | CN¥3,125 | CN¥2,438 |
| % Margin | 15.4% | 24.8% | 20.6% | 19.4% |
| EBITDA | -CN¥2,167 | CN¥716 | CN¥1,090 | CN¥1,134 |
| % Margin | -24.7% | 13% | 7.2% | 9% |
| Net Income | -CN¥2,601 | CN¥68 | CN¥141 | CN¥356 |
| % Margin | -29.7% | 1.2% | 0.9% | 2.8% |
| EPS Diluted | -1.64 | 0.05 | 0.079 | 0.13 |
| % Growth | -3,380% | -36.4% | -39.5% | – |
| Operating Cash Flow | -CN¥44 | CN¥829 | CN¥2,211 | CN¥5,079 |
| Capital Expenditures | -CN¥31 | -CN¥32 | -CN¥22 | -CN¥47 |
| Free Cash Flow | -CN¥75 | CN¥796 | CN¥2,189 | CN¥5,032 |